QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Two validated liquid chromatography-mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence method 期刊论文 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 卷号: 175, 页码: 11 作者:  Gao, Yuxiong;  Zhang, Dan;  Yang, Changyong;  Duan, Xiaotao;  Li, Xiuli 收藏  |  浏览/下载：11/0  |  提交时间：2020/07/01 Anti-CD47 monoclonal antibody  LC-MS  Adsorption issue  Electrochemiluminescence  Pharmacokinetics  Cross-validation   Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography-tandem mass spectrometry 期刊论文 DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13, 页码: 1739-1749 作者:  Li, Junling;  Li, Wei;  Dai, Xiaojian;  Zhong, Dafang;  Ding, Yaping 收藏  |  浏览/下载：5/0  |  提交时间：2020/07/01 nab-paclitaxel  bioequivalence  rapid equilibrium dialysis  unbound fraction  pharmacokinetics   Determination of hexabromocyclododecanes in sediments from the Haihe River in China by an optimized HPLC-MS-MS method 期刊论文 JOURNAL OF ENVIRONMENTAL SCIENCES, 2017, 卷号: 55, 期号: 0, 页码: 174-183 作者:  Su, Guijin;  Zhao, Yanhui;  Li, Qianqian;  Miao, Xue;  Huang, Xinchen 收藏  |  浏览/下载：16/0  |  提交时间：2018/07/26 Hexabromocyclododecane  Hplc-ms-ms  Sediment  Haihe River  Risk Assessment   Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance 期刊论文 European Journal of Medicinal Chemistry, 2017, 卷号: 135, 页码: 34-48 作者:  Zha, Gao-Feng;  Qin, Hua-Li*;  Youssif, Bahaa G. M.;  Amjad, Muhammad Wahab;  Raja, Maria Abdul Ghafoor 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/04 Epidermal growth factor receptor (EGFR)  BRAF  Focal adhesion kinase (FAK)  Tubulin polymerization  Cancer cell lines  MDR  multidrug resistance  EGFR  epidermal growth factor receptor  EMEA  European Medicines Evaluation Agency  FDA  US Food and Drug Administration  NSCLC  non-small cell lung  FAK  focal adhesion kinase  RTK  receptor tyrosine kinases  MAPK  mitogen-activated protein kinase  ABC  ATP-binding cassette  NF-kB  NF-kappaB  FERM  Four-point-one, ezrin, radixin, moesin  TMP  Ligustrazine or tetramethylpyrazine  Adr  Adriamycin  DRS  death receptors  TFN  tumor necrosis factor  PI  propidium iodide  TKIs  tyrosine kinase inhibitors  FAR  fluorescence activity ratio  HRMS  high resolution mass spectra  TLC  thin layer chromatography  UV  ultraviolet  DMEM  Dulbecco's modified Eagle's medium  DMSO  dimethyl sulfoxide  IBX  2-iodoxybenzoic acid